Patent · US Active

Tricyclic prodrugs

US10077246B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

GLACTONE PHARMA DEVELOPMENT AB · SE

Inventors

Martin Johansson · Helsingborg, SE
Olov Sterner · Eidsvold, AU

Key dates

Filing date	Mar 6, 2015
Grant date	Sep 18, 2018
Priority date	—
Expiry date	Mar 6, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/06052
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Prodrugs (I) and (Ia) of galiellactone, and derivatives thereof, are provided by reacting the parent compound, e.g. galiellactone, with a thiol. Such drugs may be administered orally to treat cancer and other proliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.